NUS Centre for Cancer Research (N2CR)

How can we tackle drug resistance to provide cancer patients with lasting relief? And what strategies are emerging to outsmart cancer’s relentless evolution? I penned an article, "Cancer Drug Resistance: Current Insights and Future Outlook （抗癌之战：药物耐药性的现状与未来）" published today in the Chinese newspaper Lianhe Zaobao (联合早报), to address these questions. In this piece, I highlight the immense challenge of drug resistance in cancer care while exploring how advances in medicine and technology may reshape cancer treatment. Cancer research continues to evolve, and I am optimistic about the possibilities these innovative strategies offer for patients worldwide. Here is the link to the article: https://lnkd.in/gJUqHzS9 You can read the PDF version below. I have also translated this article into English - it will be available to read soon. Many thanks to Yingzhu from Zaobao and Gladys from NUS YLL School of Medicine Corp Comm for their invaluable support in publishing this article! #N2CR #NUSMedicine

🌟 Exciting Opportunity! 🔍 Our multidisciplinary research team is seeking a passionate Research Assistant to profile #MultipleMyeloma and establish long-term 3D #CancerOrganoid for #DrugTesting. If you have a strong background in cell biology and a desire to contribute to groundbreaking cancer research, we want to hear from you! Join us in making a difference within a collaborative and innovative environment. Please reach out or share this opportunity with anyone who might be a great fit! Please write to me for more info, or to check out the job description here. Cancer Science Institute of Singapore N2CR - Cancer Translational Research Programme

DriverDetect, a machine learning algorithm, enhances cancer mutation prediction by combining outputs from seven tools, outperforming individual methods and adapting to new data for broad cancer analysis. Click here to read more: bit.ly/4ftkdIG #AI #machinelearning #cancer

The latest issue of N2CR INSIGHTS is out and brings you highlights of our research and latest happenings. Click to read: https://bit.ly/4foqYeL Happy reading!

Research led by N2CR member, A/Prof Polly Chen, uncovers how an RNA binding protein (DAP3) helps cancer cells grow by maintaining crucial RNA modifications, highlighting a new target for cancer treatment. #cancerresearch #rna #rnabiology

A new CAR T-cell therapy, led by N2CR members Prof Allen Yeoh and Prof Dario Campana, shows promise in treating treatment resistant T-cell acute lymphoblastic leukemia (T-ALL), with most patients achieving remission and with acceptable side effects. Read publication: https://lnkd.in/gc8DpSTU Read on The Straits Times: https://bit.ly/4dBmrEE Read on Channel News Asia: https://bit.ly/3zGaQGu #cancertreatment #CARTcelltherapy #leukemia #N2CR

Congratulations to our N2CR members who have been awarded the Distinguished Senior Clinician Award 2024!

Congratulations to all our N2CR members named in the Top 2% of Scientists Cited Worldwide!

Congratulations to our N2CR members, Prof Chng Wee Joo and Prof Lee Soo Chin on receiving the Distinguished Senior Clinician Award 2024!

A breakthrough study co-led by N2CR member A/Prof Raghav Sundar, and includes N2CR members Prof Jimmy So, A/Prof Yvonne Tay and Dr Yong Wei Peng, offers new hope for gastric cancer patients with peritoneal metastasis by uncovering key genetic changes and tumor microenvironment factors, leading to potential targeted therapies and earlier detection. Read more here: https://lnkd.in/gWWzqktJ #Gastriccancer #Cancerresearch